Srisawang Pornsuree, Harun-Or-Rashid Md, Hirosawa Tomoya, Sakamoto Junichi
Nagoya J Med Sci. 2013 Aug;75(3-4):201-12.
The efficacy of opioids for cancer pain has been proven and the World Health Organization (WHO) three-step ladder has been recommended for cancer pain relief. However, undertreatment of cancer pain has still been reported in Thailand. Identification of barriers to opioid use by the physicians and policy makers/regulators, and their level of knowledge and attitudes concerning its use are influential factors for cancer pain management (CPM). This study was performed to assess the knowledge and attitudes physicians and policy makers/regulators have regarding use of opioids for CPM. Barriers to opioid availability were also studied. A self-administered questionnaire was mailed to 300 physicians and distributed to 58 policy makers/regulators from September to October 2011. A total of 219 physicians and 47 policy makers/ regulators completed the questionnaire. Of the physicians 62.1% had inadequate knowledge and 33.8% had negative attitudes. Physicians who did not know the WHO three-step ladder were more likely to have less knowledge than those having used the WHO three-step ladder (OR = 13.0, p < 0.001). Policy makers/regulators also had inadequate knowledge (74.5%) and negative attitudes (66.0%). Policy makers/ regulators who never had CPM training were likely to have more negative attitudes than those having had training within less than one year (OR = 35.0, p = 0.005). Lack of training opportunities and periodic shortages of opioids were the greatest barriers to opioid availability for physicians and policy makers/ regulators, respectively. The strengthening of ongoing educational programs regarding opioid use for CPM, and cooperation among key groups are needed.
阿片类药物对癌症疼痛的疗效已得到证实,世界卫生组织(WHO)的三阶梯止痛法已被推荐用于缓解癌症疼痛。然而,泰国仍有报道称癌症疼痛治疗不足。识别医生以及政策制定者/监管者在使用阿片类药物方面的障碍,以及他们对其使用的知识水平和态度,是癌症疼痛管理(CPM)的影响因素。本研究旨在评估医生以及政策制定者/监管者在使用阿片类药物进行CPM方面的知识和态度。同时还研究了阿片类药物供应方面的障碍。2011年9月至10月,向300名医生邮寄了一份自填式问卷,并分发给58名政策制定者/监管者。共有219名医生和47名政策制定者/监管者完成了问卷。在医生中,62.1%的人知识不足,33.8%的人态度消极。不知道WHO三阶梯止痛法的医生比使用过WHO三阶梯止痛法的医生知识更可能不足(比值比=13.0,p<0.001)。政策制定者/监管者也存在知识不足(74.5%)和态度消极(66.0%)的情况。从未接受过CPM培训的政策制定者/监管者比在不到一年的时间内接受过培训的人态度更可能消极(比值比=35.0,p=0.005)。缺乏培训机会和阿片类药物的周期性短缺分别是医生和政策制定者/监管者获取阿片类药物的最大障碍。需要加强关于使用阿片类药物进行CPM的现行教育计划,并加强关键群体之间的合作。